Approach to the Patient: Diagnosis of Cushing Syndrome.
Savas M, Mehta S, Agrawal N, van Rossum EFC, Feelders RA.
J Clin Endocrinol Metab. 2022 Nov 23;107(11):3162-3174. doi: 10.1210/clinem/dgac492.
Pseudo-Cushing's States.
Androulakis II, Kaltsas G, Chrousos G.
2015 May 8. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–.
The difficulties of pseudo-Cushing's syndrome (or "non-neoplastic hypercortisolism").
Chabre O.
Ann Endocrinol (Paris). 2018 Jun;79(3):138-145. doi: 10.1016/j.ando.2018.04.017. Epub 2018 Apr 30.
Case report: Pheochromocytoma-induced pseudo-Cushing's syndrome.
Bobrowicz M, Nagórska A, Karpiłowska A, Rosłon M, Hubska J, Gładka A, Toutounchi S, Koperski Ł, Ambroziak U.
Front Endocrinol (Lausanne). 2024 Dec 16;15:1491873. doi: 10.3389/fendo.2024.1491873. eCollection 2024.
[Pseudo-Cushing syndrome. Physiopathologic aspects and differential diagnosis].
Ceroni L, Cota D, Pasquali R.
Minerva Endocrinol. 2000 Jun;25(2):47-54.
Hypercortisolism (Cushing Syndrome).
John TA, Anastasopoulou C.
2025 Nov 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
[Pseudo-Cushing's syndrome].
Oki S.
Nihon Rinsho. 2006 May 28;Suppl 1:607-10.
Alcohol-induced pseudo-Cushing's syndrome.
Jeffcoate W.
Lancet. 1993 Mar 13;341(8846):676-7. doi: 10.1016/0140-6736(93)90434-i.
[Pseudo-Cushing's syndrome].
Shibata H, Kojima I.
Ryoikibetsu Shokogun Shirizu. 1993;(1):413-5.
[Pseudo-Cushing states].
Romanholi DJ, Salgado LR.
Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1303-13. doi: 10.1590/s0004-27302007000800016.
